Your browser doesn't support javascript.
loading
Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo.
Winsel, S; Mäki-Jouppila, J; Tambe, M; Aure, M R; Pruikkonen, S; Salmela, A-L; Halonen, T; Leivonen, S-K; Kallio, L; Børresen-Dale, A-L; Kallio, M J.
Afiliação
  • Winsel S; 1] VTT Health, VTT Technical Research Centre of Finland, 20520 Turku, Finland [2] Centre for Biotechnology, University of Turku, 20520 Turku, Finland.
  • Mäki-Jouppila J; 1] VTT Health, VTT Technical Research Centre of Finland, 20520 Turku, Finland [2] Centre for Biotechnology, University of Turku, 20520 Turku, Finland [3] Drug Research Doctoral Programme and FinPharma Doctoral Program Drug Discovery, University of Turku, 20520 Turku, Finland.
  • Tambe M; 1] VTT Health, VTT Technical Research Centre of Finland, 20520 Turku, Finland [2] Centre for Biotechnology, University of Turku, 20520 Turku, Finland [3] Drug Research Doctoral Programme and FinPharma Doctoral Program Drug Discovery, University of Turku, 20520 Turku, Finland.
  • Aure MR; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, 0310 Oslo, Norway.
  • Pruikkonen S; 1] VTT Health, VTT Technical Research Centre of Finland, 20520 Turku, Finland [2] Turku Doctoral Programme of Molecular Medicine, University of Turku, 20520 Turku, Finland.
  • Salmela AL; 1] VTT Health, VTT Technical Research Centre of Finland, 20520 Turku, Finland [2] Turku Graduate School of Biomedical Sciences, University of Turku, 20520 Turku, Finland.
  • Halonen T; Centre for Biotechnology, University of Turku, 20520 Turku, Finland.
  • Leivonen SK; 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, 0310 Oslo, Norway [2] The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0424 Oslo, Norway.
  • Kallio L; VTT Health, VTT Technical Research Centre of Finland, 20520 Turku, Finland.
  • Børresen-Dale AL; 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, 0310 Oslo, Norway [2] The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0424 Oslo, Norway.
  • Kallio MJ; 1] VTT Health, VTT Technical Research Centre of Finland, 20520 Turku, Finland [2] Centre for Biotechnology, University of Turku, 20520 Turku, Finland.
Br J Cancer ; 111(11): 2142-51, 2014 Nov 25.
Article em En | MEDLINE | ID: mdl-25268374
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs / Mitose Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs / Mitose Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Finlândia